BridgeBio Pharma, Inc. (BBIO) Reports Material Event to SEC

BridgeBio Pharma, Inc. (NASDAQ:BBIO) filed a Form 8-K with the Securities and Exchange Commission on January 21, 2026, disclosing a material event.

BridgeBio Pharma, Inc.'s stock currently trades at $78.15 with a market capitalization of $14.1B. The Healthcare company's stock moved following the disclosure.